Oura Health disclosed plans to acquire Counsel Health, a medical artificial intelligence startup, for $625 million, contingent upon deal closure before the close of the calendar year. The announcement came during Oura’s quarterly earnings presentation.
Counsel Health operates as an AI-native primary care company that leverages artificial intelligence to generate medical responses and insights derived from user health data collected through wearable devices. The platform enables users to engage in dialogue with in-house physicians after receiving AI-generated guidance. Oura had previously integrated Counsel Health’s AI chatbot into its mobile application during the preceding months of this year.
Oura’s chief executive outlined the strategic rationale for the acquisition, characterizing it as a component of a broader initiative to integrate wearable technology, clinical artificial intelligence, and physician access through analysis of biometric information. The acquisition aligns with an objective to address three healthcare domains: preventative care interventions, acute care for temporary health issues, and specialized or chronic disease management in areas including reproductive health and cardiometabolic conditions.
Counsel Health presently operates a physician network comprising approximately 50 practitioners and employs 70 personnel who will transition to Oura following deal completion. The startup’s chief executive will assume the role of chief clinical artificial intelligence officer at Oura. Despite the acquisition, Counsel Health intends to maintain its medical AI platform as an independent offering accessible to enterprise clients such as health insurance plans, hospital systems, consumer health organizations, and employer groups.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI